In addition, since Hsp70 and CTR also interact with several pathways involved in tumorigenesis, CTR could be considered a convenient therapeutic target in GBM treatment, as has been argued elsewhere [29,118] (Figure 6). This evidence concerns the gene HSPA1A and glioblastoma.